Evidence map›Paper›PMID 35405524›Full record

ArticleAsian journal of psychiatry2022

The potential impact of Covid-19 on CNS and psychiatric sequels.

Ali Dehghani, Elham Zokaei, Seyyed Mohammad Kahani, Elaheh Alavinejad, Mohammad Dehghani, Gholam Hossein Meftahi, Mohammad Reza Afarinesh

Open access · greenAbstract read
In one paragraph

Article in Asian journal of psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Ali DehghaniDepartment of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Elham ZokaeiDepartment of Biology, Faculty of Science, Shahid Bahonar University of Kerman, Kerman, Iran.
Seyyed Mohammad KahaniDepartment of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Elaheh AlavinejadDepartment of Medical Genetics, Faculty of Medical Sciences, Tehran University of Medical Science, Tehran, Iran.
Mohammad DehghaniDepartment of Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Gholam Hossein MeftahiNeuroscience Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mohammad Reza AfarineshNeuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: r.afarinesh@kmu.ac.ir.
Kerman University of Medical Sciences · IRTarbiat Modares University · IRBaqiyatallah University of Medical Sciences · IRShahid Bahonar University of Kerman · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to its high prevalence and fatality, the current Severe Acute Respiratory Syndrome-coronavirus-2 (SARS-CoV-2) virus, which first emerged in China in 2019, quickly spread around the world and immediately became a serious global health concern. Although respiratory issues were initially the most prominent symptom of coronavirus disease 2019 (COVID-19), it became obvious rapidly that COVID-19, like many other coronavirus family members, could affect the central nervous system (CNS). During the pandemic, CNS involvement expressed itself in a variety of forms, including insomnia, anosmia, headaches, encephalopathies, encephalitis, cerebrovascular accidents, cognitive and memory impairment, and increased psychiatric disorders. Almost everyone who has been infected has at least one of these neurological symptoms, demonstrating that the virus has a high ability to impact the CNS. As the coronavirus pandemic passes its second year, the manifestations it can cause in the long run, such as its psychological sequels, have not yet been thoroughly studied. Given the high importance of this issue in today's society and due to the lack of reliable knowledge about the COVID-19 landscape on psychiatric disorders, we intend to investigate coronavirus's possible effect on mental illnesses based on available literature. Because the majority of the psychological effects of the coronavirus can continue for a long period after the pandemic ends, our research can give insight into potential psychiatric sequels associated with COVID-19.

Indexed as

COVID-19Nervous System DiseasesStrokeCentral Nervous SystemHumansPandemicsSARS-CoV-2COVID-19Neurological & psychiatric symptomsPsychiatric disorderSARS-CoV-2

Identifiers

PMID35405524
PMCPMC8982477
OpenAlexW4223571211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.